Pioneer Family Office »

Inovio Pharmaceuticals shares owned by Pioneer Family Office

Quarter-by-quarter ownership of Inovio Pharmaceuticals (INO) shares owned by Pioneer Family Office from 13F filings

Historical chart of Pioneer Family Office investment in Inovio Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Inovio Pharmaceuticals held by Pioneer Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inovio Pharmaceuticals by Pioneer Family Office

Quarter filed Position value Share count Share price at filing
2026-03-31 $505 291 1.74
2025-12-31 $505 291 1.74

More positions owned by Pioneer Family Office

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard World Inf Tech Etf (VGT)
Ishares Msci Israel Etf (EIS)
Vaneck Etf Trust Fallen Angel Hg (Principal) (ANGL)
Ishares Tr Msci Intl Vlu Ft (IVLU)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Global X Fds Defense Tech Etf (SHLD)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Vaneck Merk Gold Etf Gold Shs (OUNZ)
Apple (AAPL)
Spdr Series Trust State Street Spd (SPYM)
Ishares Tr Core Div Grwth (DGRO)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Pioneer Family Office

Top funds holding Inovio Pharmaceuticals

FMR
Vanguard Group
Henderson Group
Vanguard Capital Management
Boxer Capital Management
D. E. Shaw & Co
ADAR1 Capital Management
Millennium Management
Eversept Partners
Adage Capital Partners GP
Geode Capital Management
BlackRock
Renaissance Technologies
Diadema Partners
Susquehanna International

View all funds holding Inovio Pharmaceuticals